StockVS

TSX · Specialty Chemicals · CAD

5N Plus Inc. (VNP.TO) Stock Analysis

5N Plus Inc. (VNP.TO) is a Specialty Chemicals stock listed on TSX and quoted in Canadian Dollar.

VNP.TO

CA$25.54

+CA$0.62 (+2.49%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare VNP.TO with… →

VNP.TO Key Statistics

As of Sep 4, 2026
Trading
Open
CA$24.84
Previous Close
CA$24.92
Day's Range
24.79–27.18
52-Week Range
14.60–49.97
Volume
850.30K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.77
Valuation
Market Cap
CA$2.30B
P/E Ratio
26.60
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
21.43
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.42
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
5.14
EPS (ttm)Profit attributable to each share over the last twelve months.
0.96
Financials (FY)
Revenue (FY)
CA$391.06M+35.18%
Net Income (FY)
CA$50.57M+244.64%
Profit marginThe share of revenue left as profit after all costs and taxes.
14.13%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
89.94M
1-Year Return
+67.26%
Dividend and dates
Earnings Date
November 2, 2026estimated
Avg Volume
670.21K

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

VNP.TO Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+44.13%
2025+140.11%
2024+95.24%
2023+29.90%
2022+22.27%
2021−19.32%
2020+19.92%
2019−20.65%
2018+3.33%
2017+67.60%
2016 (partial year)−9.60%

As of September 4, 2026.

VNP.TO Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025CA$391.06MCA$50.57M12.9%
2024CA$289.28MCA$14.67M5.1%
2023CA$242.37MCA$15.40M6.4%
2022CA$264.22M−CA$23.00M−8.7%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025CA$391.06MCA$117.50MCA$76.42MCA$50.57M12.9%
2024CA$289.28MCA$77.87MCA$35.49MCA$14.67M5.1%
2023CA$242.37MCA$57.54MCA$20.53MCA$15.40M6.4%
2022CA$264.22MCA$48.51MCA$10.99M−CA$23.00M−8.7%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

VNP.TO Valuation vs Specialty Chemicals Median

Median of 71 stocks
MetricVNP.TOSpecialty Chemicals medianvs median
P/E26.6028.717% below
P/S ratio5.141.683.1x the median
Profit margin14.13%0.08%14.1 pts above

Medians across 71 Specialty Chemicals stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Analysis

Data-derived

Company Overview

5N Plus Inc. (VNP.TO) carries a market capitalisation of CA$2.30B. It is classified in the Specialty Chemicals industry, within the Basic Materials sector. Headcount on file is 849.

The 52-week range on file runs from CA$14.60 to CA$49.97. VNP.TO last closed at CA$25.54 on September 4, 2026. That is +CA$0.62 (+2.49%) against the previous close. The latest close sits 74.93% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of CA$391.06M. Against the prior fiscal year total of CA$289.28M, that is a change of +35.18%. Net income for the same year was CA$50.57M. That is +244.64% against the prior fiscal year. The reported profit margin is 14.14%. That is 14.1 percentage points above the Specialty Chemicals median of 0.08%. Trailing earnings per share are 0.96.

Across the 4 fiscal years on file, revenue moves from CA$264.22M in 2022 to CA$391.06M in 2025. Of those 4 years, 3 report positive net income.

Valuation Assessment

The trailing P/E ratio stands at 26.6. That is 7.35% below the Specialty Chemicals median of 28.71. On forward earnings the ratio is 21.43. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.42. The price-to-sales ratio is 5.14. On price-to-sales that is 3.1 times the Specialty Chemicals median of 1.68. 71 Specialty Chemicals companies report these metrics, and the medians quoted come from that group.

Beta against the wider market is reported at 1.78. Daily returns over the trailing 10 years annualize to a volatility of 51.34%. Over the trailing twelve months the price has returned +67.26%. Across 10 years the annualized return works out at +30.23%.

Growth & Income

The record shows no dividend for VNP.TO.

Across the complete calendar years on file, 2025 returned +140.11% and 2019 returned −20.65%. Of the 9 complete calendar years on file, 7 finished higher. 2026 is still running; the price is +44.13% year to date.

Peer Comparison

5N Plus Inc. (VNP.TO) operates in the Specialty Chemicals industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
5N Plus Inc. VNP.TO CA$2.30B 26.6
Linde plc LIN CA$220.15B 30.9
The Sherwin-Williams Company SHW CA$81.01B 30.8
Ecolab Inc. ECL CA$78.29B 37.4

The Specialty Chemicals industry average P/E ratio is 28.7x. 5N Plus Inc. trades at a P/E of 26.6.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Specialty Chemicals Stocks

View all Specialty Chemicals stocks →

Popular Basic Materials Stocks

View all Basic Materials stocks →

About 5N Plus Inc.

5N Plus Inc. produces and sells specialty semiconductors and performance materials in the Americas, Europe, Asia, and internationally. It offers semiconductor compounds, semiconductor wafers, metals, epitaxial semiconductor substrates, ultra-high purity metals, space solar cells, and assemblies. The company also provides active pharmaceutical ingredients, specialized chemicals, commercial grade metals, alloys, engineered powders, and recycling services. It serves renewable energy, security, space, pharmaceutical, medical imaging, and industrial application markets. The company is headquartered in Montreal, Canada.

Visit website →